-
1
-
-
0027408714
-
Sumatriptan
-
Bateman DN. Sumatriptan. Lancet 1993;341:221-3
-
(1993)
Lancet
, vol.341
, pp. 221-223
-
-
Bateman, D.N.1
-
2
-
-
0030008549
-
Determination of sumatriptan succinate in human plasma by high-performance liquid chromatography with coulometric detection and utilization of solid-phase extraction
-
Franklin M, Odontiadis J, Clement EM. Determination of sumatriptan succinate in human plasma by high-performance liquid chromatography with coulometric detection and utilization of solid-phase extraction. J Chromatogr B Biomed Appl 1996 ; 681 : 416-420.
-
(1996)
J Chromatogr B Biomed Appl
, vol.681
, pp. 416-420
-
-
Franklin, M.1
Odontiadis, J.2
Clement, E.M.3
-
3
-
-
0030011540
-
Fully automated assay for the determination of sumatriptan in human serum using solid-phase extraction and high-performance liquid chromatography with electrochemical detection
-
Dunne M, Andrew P. Fully automated assay for the determination of sumatriptan in human serum using solid-phase extraction and high-performance liquid chromatography with electrochemical detection. J Pharm Biomed Anal 1996 ; 14 : 721-726.
-
(1996)
J Pharm Biomed Anal
, vol.14
, pp. 721-726
-
-
Dunne, M.1
Andrew, P.2
-
4
-
-
0027159483
-
Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detection
-
Andrew PD, Birch HL, Phillpot DA. Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detection. J Pharm Sci 1993 ; 82 : 73-76.
-
(1993)
J Pharm Sci
, vol.82
, pp. 73-76
-
-
Andrew, P.D.1
Birch, H.L.2
Phillpot, D.A.3
-
5
-
-
2542446197
-
High performance liquid chromatographic method for the determination of sumatriptan with fluorescence detection in human plasma
-
Ge Z, Tessier E, Neirinck L, Zhu Z. High performance liquid chromatographic method for the determination of sumatriptan with fluorescence detection in human plasma. J Chromatogr B 2004 ; 806 : 299-303.
-
(2004)
J Chromatogr B
, vol.806
, pp. 299-303
-
-
Ge, Z.1
Tessier, E.2
Neirinck, L.3
Zhu, Z.4
-
6
-
-
0033950742
-
Determination of Antimigraine Compounds Rizatriptan, Zolmitriptan, Naratriptan and Sumatriptan in Human Serum by Liquid Chromatography Electrospray Tandem Mass Spectrometry
-
Vishwanathan K, Bartlett MG, Stewart JT. Determination of Antimigraine Compounds Rizatriptan, Zolmitriptan, Naratriptan and Sumatriptan in Human Serum by Liquid Chromatography Electrospray Tandem Mass Spectrometry. Rapid Communications in Mass Spectrometry 2000; 14: 168-172.
-
(2000)
Rapid Communications in Mass Spectrometry
, vol.14
, pp. 168-172
-
-
Vishwanathan, K.1
Bartlett, M.G.2
Stewart, J.T.3
-
7
-
-
0029670562
-
1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
-
1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Chromatogr A 1996 ; 726 : 115-124.
-
(1996)
J Chromatogr A
, vol.726
, pp. 115-124
-
-
McLoughlin, D.A.1
Olah, T.V.2
Ellis, J.D.3
Gilbert, J.D.4
Halpin, R.A.5
-
8
-
-
0031005146
-
A method using a liquid chromatographic-electrospray-mass spectrometric assay for the determination of antimigraine compounds: Preliminary pharmacokinetics of MDL 74,721 sumatriptan and naratriptan, in rabbit
-
Dulry BD, Petty MA, Schoun J, David M, Huebert ND. A method using a liquid chromatographic-electrospray-mass spectrometric assay for the determination of antimigraine compounds: preliminary pharmacokinetics of MDL 74,721 sumatriptan and naratriptan, in rabbit. J Pharm Biomed Anal 1997 ;15 : 1009-1020.
-
(1997)
J Pharm Biomed Anal
, vol.15
, pp. 1009-1020
-
-
Dulry, B.D.1
Petty, M.A.2
Schoun, J.3
David, M.4
Huebert, N.D.5
-
9
-
-
0030824940
-
Stability indicating HPLC method for the determination of sumatriptan succinate in pharmaceutical preparations and its application in dissolution rate studies
-
Shigh S, Jain R. Stability indicating HPLC method for the determination of sumatriptan succinate in pharmaceutical preparations and its application in dissolution rate studies. Indian Drugs 1997 ; 34 : 527-531.
-
(1997)
Indian Drugs
, vol.34
, pp. 527-531
-
-
Shigh, S.1
Jain, R.2
-
10
-
-
0029804629
-
Reverse phase HPLC and colorimetric determination of sumatriptan succinate in its drug form
-
Avadhanulu AB, Srinivas JS, Anjaneyulu Y. Reverse phase HPLC and colorimetric determination of sumatriptan succinate in its drug form. Indian Drugs 1996 ; 33 : 334-337.
-
(1996)
Indian Drugs
, vol.33
, pp. 334-337
-
-
Avadhanulu, A.B.1
Srinivas, J.S.2
Anjaneyulu, Y.3
-
11
-
-
0030012996
-
Reverse phase HPLC determination of amlodipine besylate in drug and its pharmaceutical dosage forms
-
Avadhanulu AB, Srinivas KS, Anjaneyulu Y. Reverse phase HPLC determination of amlodipine besylate in drug and its pharmaceutical dosage forms. Indian Drugs 1996 ; 33 : 36-40.
-
(1996)
Indian Drugs
, vol.33
, pp. 36-40
-
-
Avadhanulu, A.B.1
Srinivas, K.S.2
Anjaneyulu, Y.3
-
12
-
-
0031817164
-
High performace liquid chromatographic determination of sumatriptan succinate from pharmaceutical preparation
-
Shirsat VA, Gabhe SY, Deshpande SG. High performace liquid chromatographic determination of sumatriptan succinate from pharmaceutical preparation. Indian Drugs 1998 ; 35 : 404-407.
-
(1998)
Indian Drugs
, vol.35
, pp. 404-407
-
-
Shirsat, V.A.1
Gabhe, S.Y.2
Deshpande, S.G.3
-
13
-
-
0037026372
-
Development and validation of an LC assay for sumatriptan succinate residues on surfaces in the manufacture of pharmaceuticals
-
Nozal MJ, Bernal JL, Toribio L, Martyn MT, Diez F J. Development and validation of an LC assay for sumatriptan succinate residues on surfaces in the manufacture of pharmaceuticals. J Pharm Biomed Anal 2002 ; 30 : 285-291.
-
(2002)
J Pharm Biomed Anal
, vol.30
, pp. 285-291
-
-
Nozal, M.J.1
Bernal, J.L.2
Toribio, L.3
Martyn, M.T.4
Diez, F.J.5
-
14
-
-
0037774549
-
Validation of the quantitative analytical procedures. Harmonization of the steps
-
Hubert PH, Chiap P, Crommen J, Boulanger B, Chapuzet E, Mercier N, Bervoas-Martin S, Chevalier P, Grandjean D, Lagorce P, Lallier M, Laparra MC, Laurentie M, Nivet JC. Validation of the quantitative analytical procedures. Harmonization of the steps. S.T.P. Pharma practise 2003; 13 : 101-138.
-
(2003)
S.T.P. Pharma Practise
, vol.13
, pp. 101-138
-
-
Hubert, P.H.1
Chiap, P.2
Crommen, J.3
Boulanger, B.4
Chapuzet, E.5
Mercier, N.6
Bervoas-Martin, S.7
Chevalier, P.8
Grandjean, D.9
Lagorce, P.10
Lallier, M.11
Laparra, M.C.12
Laurentie, M.13
Nivet, J.C.14
-
15
-
-
0033030353
-
The SFSTP Guide on the validation of chromatographic methods for drug bioanalysis: From the Washington Conference to the laboratory
-
Hubert Ph, Chiap P, Crommen J, Boulanger B, Chapuzet E, Mercier N, Bervoas-Martin S, Chevalier P, Grandjean D, Lagorce Ph, Laparra MC, Laurentie M, Nivet JC. The SFSTP Guide on the validation of chromatographic methods for drug bioanalysis : from the Washington Conference to the laboratory. Anal Chim Acta 1999 ; 391 : 135-148.
-
(1999)
Anal Chim Acta
, vol.391
, pp. 135-148
-
-
Hubert, Ph.1
Chiap, P.2
Crommen, J.3
Boulanger, B.4
Chapuzet, E.5
Mercier, N.6
Bervoas-Martin, S.7
Chevalier, P.8
Grandjean, D.9
Lagorce, Ph.10
Laparra, M.C.11
Laurentie, M.12
Nivet, J.C.13
-
16
-
-
0042625050
-
An analysis of the SFSTP guide on validation of bioanalytical methods: Progress and limitations
-
Boulanger B, Dewe W, Chiap P, Crommen J, Hubert Ph. An analysis of the SFSTP guide on validation of bioanalytical methods : progress and limitations. J Pharm Biomed Anal 2003 ; 32 : 753-765.
-
(2003)
J Pharm Biomed Anal
, vol.32
, pp. 753-765
-
-
Boulanger, B.1
Dewe, W.2
Chiap, P.3
Crommen, J.4
Hubert, Ph.5
-
17
-
-
0003484310
-
-
U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), May
-
Guidance for industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), May 2001.
-
(2001)
Guidance for Industry: Bioanalytical Method Validation
-
-
|